Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016		Dec. 31, 2015		Dec. 31, 2014
Cash flows from operations
Net income	$ 4,965	[1]	$ 968	[2]	$ 2,497
Adjustments to reconcile income from continuing operations to net cash from operating activities:
Loss (income) from discontinued operations, net of tax	1		(575)		(2,040)
Depreciation and amortization	800		759		792
Deferred income taxes	(302)		(50)		(117)
Stock compensation	115		126		126
Realized excess tax benefits from stock issued under employee benefit plans	(39)		(7)		(15)
Net periodic pension benefit and OPEB costs	116		227		219
Business optimization items	285		130		(6)
Net realized gains on Baxalta common stock	(4,387)
Infusion pump and other product-related charges	(18)		(28)		93
Other	264		42		19
Changes in balance sheet items
Accounts and other current receivables, net	15		(4)		(93)
Inventories	80		(118)		(143)
Accounts payable and accrued liabilities	(197)		236		(37)
Business optimization and infusion pump payments	(189)		(112)		(124)
Other	115		(341)		(17)
Cash flows from operations – continuing operations	1,624		1,253		1,154
Cash flows from operations – discontinued operations	30		518		2,061
Cash flows from operations	1,654		1,771		3,215
Cash flows from investing activities
Capital expenditures	(719)		(911)		(925)
Acquisitions and investments, net of cash acquired	(48)		(34)		(95)
Divestitures and other investing activities	37		84		99
Cash flows from investing activities – continuing operations	(730)		(861)		(921)
Cash flows from investing activities – discontinued operations	15		(946)		(621)
Cash flows from investing activities	(715)		(1,807)		(1,542)
Cash flows from financing activities
Issuances of debt	1,641		6,868		41
Payments of obligations	(1,381)		(3,786)		(1,029)
Debt extinguishment costs	(16)		(114)
(Decrease) increase in debt with original maturities of three months or less, net	(300)		(575)		875
Transfer of cash and equivalents to Baxalta			(2,122)
Cash dividends on common stock	(268)		(910)		(1,095)
Proceeds and realized excess tax benefits from stock issued under employee benefit plans	325		200		369
Purchases of treasury stock	(292)				(550)
Other	(33)		(42)		(13)
Cash flows from financing activities	(324)		(481)		(1,402)
Effect of foreign exchange rate changes on cash and equivalents	(27)		(195)		(79)
Increase (decrease) in cash and equivalents	588		(712)		192
Cash and equivalents at beginning of year	2,213		2,925		2,733
Cash and equivalents at end of year	2,801		2,213		2,925
Supplemental schedule of non-cash investing and financing activities
Net proceeds on Retained Shares transactions	4,387
Payment of obligations in exchange for Retained Shares	3,646
Exchange of Baxter shares with Retained Shares	611
Other supplemental information
Interest paid, net of portion capitalized	99		178		208
Income taxes paid	$ 500		$ 466		$ 726

[1] The first quarter of 2016 included benefits of $3.1 billion related to business optimization, separation-related costs, Retained Stake transactions, a loss on debt extinguishment, and product-related items. The second quarter of 2016 included benefits of $1.0 billion related to business optimization, separation-related costs, Retained Stake transactions, and asset impairment. The third quarter of 2016 included charges of $155 million related to business optimization, separation-related costs, a loss on debt extinguishment, and a tax matter. The fourth quarter of 2016 included charges of $47 million related to business optimization, separation-related costs, and reserve items and adjustments.

[2] The first quarter of 2015 included charges of $29 million related to business optimization, Gambro integration costs, and separation-related costs. The second quarter of 2015 included benefits of $5 million related to business optimization, Gambro integration costs, separation-related costs, and tax and legal reserves. The third quarter of 2015 included charges of $191 million related to business optimization, Gambro integration costs, separation-related costs, a loss on debt extinguishment, and product-related items. The fourth quarter of 2015 included $17 million related to business optimization, Gambro integration costs, product-related items, separation-related costs, and reserve items and adjustments.